Plasmos Medaids Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.43 M
as on 16-11-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.00 M
as on 16-11-2024
- Revenue -8.36%
(FY 2023)
- Profit 106.40%
(FY 2023)
- Ebitda 99.06%
(FY 2023)
- Net Worth 7.15%
(FY 2023)
- Total Assets 0.30%
(FY 2023)
About Plasmos Medaids
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.43 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sriram Ravindranath, Mohan Gangaraju, Meshach Sadhu, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100KA2012PTC065724
- Company No.
065724
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Plasmos Medaids?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Gangaraju  | Director | 03-Sep-2012 | Current |
| Mahesh Nerkar | Director | 03-Sep-2012 | Current |
| Sriram Ravindranath | Director | 03-Sep-2012 | Current |
| Meshach Sadhu | Director | 03-Sep-2012 | Current |
Financial Performance and Corporate Structure Insights of Plasmos Medaids.
Plasmos Medaids Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.36% decrease. The company also saw a substantial improvement in profitability, with a 106.4% increase in profit. The company's net worth moved up by a moderate rise of 7.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plasmos Medaids?
In 2023, Plasmos Medaids had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Mandya Multi Speciality Hospital Private LimitedActive 3 years 9 months
Sriram Ravindranath is a mutual person
- Vidyaranya Multispeciality Hospital Private LimitedActive 11 years 3 months
Sriram Ravindranath is a mutual person
- Nandhana Superspeciality Eye Care Private LimitedActive 8 years 10 months
Sriram Ravindranath is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 13 Sep 2014 | ₹1.00 M | Satisfied |
How Many Employees Work at Plasmos Medaids?
Plasmos Medaids has a workforce of 5 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plasmos Medaids, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plasmos Medaids's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
